stockrowPacific Biosciences of California, Inc. (PACB) vs VAREX IMAGING (VREX)
- Pacific Biosciences of California, Inc. PACB 2.30 −5.35%
- VAREX IMAGING VREX 18.44 0.00%
Pacific Biosciences of California, Inc. and VAREX IMAGING are both Medical Devices companies. Pacific Biosciences of California, Inc. and VAREX IMAGING are of similar size ($783.0M and $755.3M). Pacific Biosciences of California, Inc. has negative trailing earnings, so its P/E is not meaningful; VAREX IMAGING trades at 34.8×. VAREX IMAGING grew revenue faster over the last twelve months: 5.31% against 4.41%. VAREX IMAGING has the higher net margin (2.55% vs −81.3%) and the higher return on invested capital (5.95% vs 0.00%). Across the 17 metrics below, VAREX IMAGING leads on 10 and Pacific Biosciences of California, Inc. on 7.
Valuation
Profitability
| Metric | PACB | VREX | Medical Devices median |
|---|---|---|---|
| Gross margin | 34.40% | 34.32% | 57.76% |
| Operating margin | (81.27%) | 8.35% | (15.07%) |
| Net margin | (81.31%) | 2.55% | (14.45%) |
| Free cash flow margin | (84.85%) | (2.34%) | (3.88%) |
| Return on equity | 1,037.83% | 4.51% | (10.35%) |
| Return on assets | (17.22%) | 2.03% | (17.26%) |
| Return on invested capital | 0.00% | 5.95% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack